ArticlePloS one2020

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.

Mengshi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.